A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

Simple item page
dc.contributor.authorid0000-0002-8524-5087
dc.contributor.coauthorSpelman, Tim
dc.contributor.coauthorOzakbas, Serkan
dc.contributor.coauthorAlroughani, Raed
dc.contributor.coauthorTerzi, Murat
dc.contributor.coauthorHodgkinson, Suzanne
dc.contributor.coauthorLaureys, Guy
dc.contributor.coauthorKalincik, Tomas
dc.contributor.coauthorVan der Walt, Anneke
dc.contributor.coauthorYamout, Bassem
dc.contributor.coauthorLechner-Scott, Jeannette
dc.contributor.coauthorSoysal, Aysun
dc.contributor.coauthorKuhle, Jens
dc.contributor.coauthorSanchez-Menoyo, Jose Luis
dc.contributor.coauthorMorgado, Yolanda Blanco
dc.contributor.coauthorSpitaleri, Daniele L. A.
dc.contributor.coauthorvan Pesch, Vincent
dc.contributor.coauthorHorakova, Dana
dc.contributor.coauthorAmpapa, Radek
dc.contributor.coauthorPatti, Francesco
dc.contributor.coauthorMacdonell, Richard
dc.contributor.coauthorAl-Asmi, Abdullah
dc.contributor.coauthorGerlach, Oliver
dc.contributor.coauthorOh, Jiwon
dc.contributor.coauthorTundia, Namita
dc.contributor.coauthorWong, Schiffon L.
dc.contributor.coauthorButzkueven, Helmut
dc.contributor.coauthorMSBase Study Grp
dc.contributor.departmentN/A
dc.contributor.kuauthorAltıntaş, Ayşe
dc.contributor.kuprofileFaculty Member
dc.contributor.researchcenterKoç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid11611
dc.date.accessioned2025-01-19T10:28:14Z
dc.date.issued2023
dc.description.abstractWhat is this summary about?Patient registries contain anonymous data from people who share the same medical condition. The MSBase registry contains information from over 80,000 people living with multiple sclerosis (MS) across 41 countries.Using information from the MSBase registry, the GLIMPSE (Generating Learnings In MultiPle SclErosis) study looked at real-life outcomes in 3475 people living with MS who were treated with cladribine tablets (Mavenclad((R))) compared with other oral treatments.What were the results?Results showed that people treated with cladribine tablets stayed on treatment for longer than other treatments given by mouth. They also had fewer relapses (also called flare ups of symptoms) than people who received a different oral treatment for their MS.What do the results mean?The results provide evidence that, compared with other oral treatments for MS, cladribine tablets are an effective medicine for people living with MS.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue4
dc.description.openaccesshybrid
dc.description.publisherscopeInternational
dc.description.volume13
dc.identifier.doi10.2217/nmt-2023-0005
dc.identifier.eissn1758-2032
dc.identifier.issn1758-2024
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85166398818
dc.identifier.urihttps://doi.org/10.2217/nmt-2023-0005
dc.identifier.urihttps://hdl.handle.net/20.500.14288/25666
dc.identifier.wos1025040700002
dc.keywordsCladribine tablets
dc.keywordsDimethyl fumarate (Tecfidera(& REG
dc.keywords))
dc.keywordsFingolimod (Gilenya(& REG
dc.keywords))
dc.keywordsLay summary
dc.keywordsMultiple sclerosis
dc.keywordsRelapses
dc.keywordsTeriflunomide (Aubagio(& REG
dc.keywords))
dc.keywordsTreatment options
dc.languageen
dc.publisherFuture Medicine Ltd
dc.sourceNeurodegenerative Disease Management
dc.subjectClinical neurology
dc.titleA plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry
dc.typeJournal Article

Files

Collections

Publications without Fulltext